‘Backup’ pacemaker discovery in goats could have important implications for human hearts
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Catch up on part one of our exclusive webinar series to hear Dr. Frank Peacock dispel the four lies of high-sensitivity troponin
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar
Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics
Advancement can enable greater certainty for providers and better outcomes for patients
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
Learn about why patients are admitted to an ICU, the physiological support, monitoring, and treatments available and the impact COVID-19 globally
Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months
The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable
Explore ways to improve time to result in critical pathways such as sepsis
Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline